Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Project factsheets
The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.
Displaying 12 projects/programmes
Biomarkers in atopic dermatitis and psoriasis
Be The Cure
H2O Health outcomes observatory
Health initiatives in psoriasis and psoriatic arthritis consortium European states
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases
Rheuma Tolerance for Cure
Unrestricted leveraging of targets for research advancement and drug discovery
